Eric Doherty is a healthcare executive dedicated to advancing global health through innovation. His expertise spans artificial intelligence, data analytics, and healthcare commercialization, with a focus on improving patient access, quality, and care innovations.
Eric’s experiences have him leading $250M-$500M organizations, to leading business units within $30B-$100B organizations, globally, including GlaxoSmithKline, Abbott Laboratories, UVANTA Specialty Pharmacy Systems, AstraZeneca, GLOCK GmbH, and PERSOWN, Inc.
He holds dual MBAs in International Marketing and Management (from Washington University and St. Louis University), as well as executive certifications from Harvard University (Leadership) and St. Louis University (Global Operational Leadership).
Eric is now the President and CEO of DPE International, Inc.-An International Healthcare Consulting Firm specializing in helping businesses with financial advice, operations and processes, regulations and compliance, business development. Those specialties range from: